New Key Statistics Module, Z-Score and F-Score
TSX:AVCN Key Ratios
Market Cap C$ M | 23.99 |
Enterprise Value C$ M | 24.91 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 0.99 |
Price/Free Cash Flow | 81.67 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 22.00 |
EPS (TTM) C$ | -0.09 |
Beneish M-Score | 1.35 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 33.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.70 |
EV-to-EBITDA | -4.24 |
PEG | -- |
Shares Outstanding M | 97.91 |
Net Margin (%) | -32.86 |
Operating Margin % | -31.26 |
Pre-tax Margin (%) | -32.82 |
Quick Ratio | 0.32 |
Current Ratio | 0.67 |
ROA % (ttm) | -33.51 |
ROE % (ttm) | -1,234.17 |
ROIC % (ttm) | -45.99 |
Dividend Yield % | -- |
Altman Z-Score | -5.64 |
TSX:AVCN Number of Guru Trades
TSX:AVCN Volume of Guru Trades
Gurus Latest Trades with TSX:AVCN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:AVCN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Avicanna Inc Insider Transactions
No Available Data